Attitudes toward the genetic testing of children among adults in a Utah- based kindred tested for a BRCA1 mutation

American Journal of Medical Genetics

Volumn 92, Issue 1, 2000, Pages 25-32

  Hamann, Heidi A ^a   Croyle, Robert T ^b   Venne, Vickie L ^c   Baty, Bonnie J ^d   Smith, Ken R ^a,c   Botkin, Jeffrey R ^c,d  

^a UNIVERSITY OF UTAH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

BRCA1 testing; Children; Ethics; Patients' attitudes

Indexed keywords

BRCA1 PROTEIN;

ADULT; ARTICLE; ATTITUDE; BREAST CANCER; CANCER SUSCEPTIBILITY; CHILD; DIAGNOSTIC TEST; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ETHICS; OVARY CANCER; PRIORITY JOURNAL;

EMPIRICAL APPROACH; GENETICS AND REPRODUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; BREAST NEOPLASMS; CHILD; FAMILY HEALTH; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; OVARIAN NEOPLASMS; PUBLIC OPINION; UTAH;

EID: 0034192754     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(20000501)92:1<25::AID-AJMG5>3.0.CO;2-Y     Document Type: Article

References (40)

1. ASHG/ACMG (American Society of Human Genetics Board of Directors and American College of Medical Genetics Board of Directors). 1995. ASHG/ACMG report - points to consider: ethical, legal, and psycho-social implications of genetic testing in children and adolescents. Am J Hum Genet 57:1233-1241.
2. Baty BJ, Venne VL, McDonald J, Croyle RT, Halls C, Nash JE, Botkin JR. 1997. BRCA1 testing: genetic counseling protocol development and counseling issues. J Genet Counsel 6:223-244.
3. Benkendorf JL, Reutenauer JE, Hughes CA, Eads N, Willison J, Powers M, Lerman C. 1997. Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility. Am J Med Genet 73:296-303.
4. Binedell J, Soldan JR, Scourfield J, Harper PS. 1996. Huntington's disease predictive testing: the case for an assessment approach to requests from adolescents. J Med Genet 33:912-918.
5. Botkin JR, Croyle RT, Smith KR, Baty, BJ, Lerman, C, Goldgar DE, Ward JM, Flick BJ, Nash JE. 1996. A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing. J Natl Cancer Inst 88:872-882.
6. Burke W, Daly M, Garber J, Botkin JR, and the Cancer Genetics Studies Consortium, Ethical, Legal, and Social Implications Branch, NCHGR. 1997. Recommendations for follow-up care of individuals with an inherited predisposition to cancer: BRCA1 and BRCA2. JAMA 277:997-1003.
7. Clarke A. 1994. The genetic testing of children (Working Party of the Clinical Genetics Society, UK). J Med Genet 31:785-797.
8. Clayton EW. 1995. Removing the shadow of the law from the debate about genetic testing of children. Am J Med Genet 57:630-634.
9. Croyle RT, Smith KR, Botkin JR, Baty B, Nash J. 1997. Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol 16:63-72.
10. Easton DF, Bishop DT, Ford D, Crockford GP, Breast Cancer Linkage Consortium. 1993. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 52:678-701.
11. Easton DF, Ford D, Bishop DT, Breast Cancer Linkage Consortium. 1995. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56:265-271.
12. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE, Breast Cancer Linkage Consortium. 1994. Risks of cancer in BRCA1-mutation carriers. Lancet 343:692-695.
13. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BAJ, Gayther SA, Birch JM, Lindblom A, Stoppa-Lyonnet D, Bignon Y, Borg A, Hamann U, Haites N, Scott RJ, Maugard CM, Vasen H, Seitz S, Cannon-Albright LA, Schofield A, Zelada-Hedman M, Breast Cancer Linkage Consortium. 1998. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676-689.
14. Geller G, Bernhardt BA, Doksum T, Helzsouer KJ, Wilcox P, Holtzman NA. 1998. Decision-making about breast cancer susceptibility testing: how similar are the attitudes of physicians, practitioners, and at-risk women? J Clin Oncol 16:2868-2976.
15. Goldgar DE, Fields P, Lewis CM, Tran TD, Cannon-Albright LA, Ward JH, Swensen J, Skolnick MH. 1994. A large kindred with 17q-linked breast and ovarian cancer: genetic, phenotypic, and genealogical analysis. J Natl Cancer Inst 86:200-209.
16. Heaton TB, Goodman KL. 1985. Religion and family formation. Rev Religious Res 26:343-359.
17. Horowitz M, Wilner N, Alvarez W. 1979. Impact of event scale: a measure of subjective stress. Psychosom Med 41:209-218.
18. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Trock, B, Main D, Lynch J, Fulmore C, Snyder C, Lemon SJ, Conway T, Tonin P, Lenoir G, Lynch H. 1996. BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes. JAMA 275:1885-1892.
19. Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E, Shohat M, Weber BL, Beller U, Lahad A, Halle D. 1997. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am J Hum Genet 60:1059-1067.
20. Li FR, Garber JE, Friend SH, Strong LC, Patenaude AF, Juenget ET, Reilly PR, Correa P, Fraumeni JF Jr. 1992. Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. J Natl Cancer Inst 523:331-344.
21. Ludlow DH. 1992. Encyclopedia of Mormonism, vols. 1-5. New York: Macmillan.
22. Lynch HT, Lemon SJ, Durham C, Tinley ST, Connolly C, Lynch JF, Surdam J, Orinion E, Slominski-Caster S, Watson P, Lerman C, Tonin P, Lenoir G, Serova O, Narod S. 1997. A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer 79:2219-2228.
23. Meissen GJ, Bercheck RL. 1987. Intended use of predictive testing by those at risk for Huntington disease. Am J Med Genet 26:283-293.
24. Michie S, Marteau TM. 1996. Predictive genetic testing in children: the need for psychological research. Br J Health Psychol 1:3-14.
25. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tanh T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayanath P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71.
26. NSGC (National Society of Genetic Counselors). 1995a. Prenatal and childhood testing for adult-onset disorders. Perspect Genet Counsel 17:5.
27. NSGC (National Society of Genetic Counselors). 1995b. The prenatal and childhood testing resolution. Perspect Genet Counsel 17:8-10.
28. Offit K. 1998. Clinical cancer genetics: risk counseling and management. New York: Wiley-Liss.
29. Patenaude AF, Basili L, Fairclough DL, Li FP. 1996. Attitudes of 47 mothers of pediatric oncology patients toward genetic testing for cancer predisposition. J Clin Oncol 14:415-421.
30. Pelias MZ. 1994. Genetic testing in children and adolescents: unresolved issues. American Society of Human Genetics Annual Meeting, Montreal, Canada, October 21, 1994.
31. Smith KR, Shipman JK. 1996. Marriage and family life. In: Heaton TB, Hirsch TA, Chadwick BA, editors. Utah in the 1990s: a demographic perspective. Salt Lake City: Signature, p 91-104.
32. Spielberger CD. 1983. State-Trait Anxiety Inventory for adults (form X). Palo Alto, CA: Mind Garden.
33. Spielberger CD, Gorsuch RL, Lushene RE. 1970. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
34. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA. 1997. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401-1408.
35. Tabachnick BG, Fidell LS. 1996. Using multivariate statistics, 3rd ed. New York: Harper Collins.
36. Task Force on Genetic Testing, National Institutes of Health - Department of Energy Working Group on Ethical, Legal, and Social Implications of Human Genome Research. 1997. Promoting safe and effective genetic testing in the United States. Bethesda, MD: National Institutes of Health.
37. Wertz DC, Reilly PR. 1997. Laboratory policies and practices for the genetic testing of children: a survey of the Helix network. Am J Hum Genet 61:1163-1168.
38. Wertz DC, Fanos JH, Reilly PR. 1994. Genetic testing for children and adolescents: who decides? JAMA 272:875-881.
39. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod S, Lenior GM, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Ormiston W, McManus R, Pye C, Lewis CM, Cannon-Albright LA, Peto J, Ponder BAJ, Skolnick MH, Easton DF, Goldgar DE, Stratton MR. 1995. Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792.
40. Zilberg NJ, Weiss DS, Horowitz MJ. 1982. Impact of event scale: a cross-validation study and some empirical evidence supporting a conceptual model of stress response systems. J Consult Clin Psychol 50:407-414.